Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SYRE | AZN | AMGN | GILD | VRTX |
| Company | Spyre Therapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 33.95 | 90.37 | 329.09 | 120.98 | 455.65 |
| High | 34.96 | 90.83 | 329.67 | 122.37 | 457.17 |
| Low | 33.45 | 89.67 | 321.62 | 120.59 | 439.80 |
| Latest | 34.79 | 90.79 | 321.55 | 120.96 | 440.26 |
| Change | +1.34 | +0.61 | -8.34 | -0.26 | -15.22 |
| % Change | +4.01% | +0.68% | -2.53% | -0.21% | -3.34% |
| Volume | 652,021 | 5,053,178 | 1,607,575 | 2,959,159 | 929,970 |
| 20-Day Average Volume | 657,038 | 5,488,185 | 2,827,278 | 6,819,385 | 1,390,392 |
| Previous Close | 33.45 | 90.18 | 329.89 | 121.22 | 455.48 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 27.12 | 90.13 | 337.59 | 124.46 | 434.61 |
| 20-Day Raw Stochastic | 98.75% | 57.59% | 9.74% | 33.97% | 58.99% |
| 20-Day Relative Strength | 76.42 | 60.13 | 49.79 | 47.86 | 56.02 |
| Weighted Alpha | +106.43 | +39.35 | +19.84 | +28.72 | -1.49 |
| Today's Opinion | 100% Buy | 100% Buy | 80% Buy | 80% Buy | 24% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 80% Buy | 80% Buy | 40% Buy |
| Last Month's Opinion | 88% Buy | 100% Buy | 56% Buy | 100% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +21.09% since 12/01/25 | +0.03% since 12/01/25 | -4.54% since 12/01/25 | -2.63% since 12/01/25 | +3.85% since 12/01/25 |
| Low | 28.16 on 12/02/25 | 89.68 on 12/08/25 | 321.62 on 12/08/25 | 120.38 on 12/05/25 | 424.06 on 12/02/25 |
| High | 34.87 on 12/08/25 | 91.28 on 12/03/25 | 346.38 on 12/03/25 | 125.60 on 12/03/25 | 463.85 on 12/03/25 |
| 1-Month | |||||
| %Chg | +54.11% since 11/07/25 | +7.06% since 11/07/25 | +0.61% since 11/07/25 | +1.87% since 11/07/25 | +7.94% since 11/07/25 |
| Low | 21.63 on 11/11/25 | 85.85 on 11/10/25 | 319.54 on 11/10/25 | 117.13 on 11/10/25 | 410.50 on 11/10/25 |
| High | 34.87 on 12/08/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | +108.69% since 09/08/25 | +11.02% since 09/08/25 | +14.98% since 09/08/25 | +4.47% since 09/08/25 | +11.82% since 09/08/25 |
| Low | 14.51 on 09/22/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 34.87 on 12/08/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +104.51% since 06/06/25 | +24.25% since 06/06/25 | +10.96% since 06/06/25 | +7.65% since 06/06/25 | -1.89% since 06/06/25 |
| Low | 13.93 on 06/17/25 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 34.87 on 12/08/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,595,453 | 279,686,592 | 177,639,520 | 150,395,232 | 115,563,928 |
| Shares Outstanding, K | 77,592 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -208,020,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -11,180,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 3.14 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.15 on 11/04/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 11/06/25 | 11/06/25 | 11/04/25 | 10/30/25 | 11/03/25 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 09/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 11/21/25 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.70 | 15.55 | 14.97 | 29.87 |